Compare Adaptive Biotechnologies Corp (ADPT) vs Ishares Msci Italy ETF (EWI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Ishares Msci Italy ETF — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while Ishares Msci Italy ETF trades at $60.07. The key difference: Ishares Msci Italy ETF is trading nearer its 52-week high, Adaptive Biotechnologies Corp nearer its low. Which is the better fit depends on your goals.
| ADPT | EWI | |
|---|---|---|
Market Cap | $3.33B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $22.37 | $61.14 |
52-Week Low | $10.24 | $47.32 |
Enterprise Value | $3.19B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
EWI trades at $61.14, up 0.84% today, with a bullish technical signal driven by moving averages. The stock recently hit a 52-week high (Zacks Investment Research, 2026-06-10), supported by improving Italian industrial data. A dividend of $1.17 is scheduled for payment on June 18, 2026. However, key valuation ratios like P/E and P/S are unavailable, limiting fundamental clarity.
Outlook is mixed: technical strength and European equity inflows (Proactive Investors, 2026-07-07) offer upside, but stagflation risks in Italy (Seeking Alpha, 2026-06-04) and ECB rate hikes (Bloomberg, 2026-06-11) pose headwinds. Investors should weigh bullish momentum against macroeconomic uncertainties and incomplete financial data.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Ishares Msci Italy ETF
EWI is a country-specific ETF that tracks the performance of the Italian equity market. It provides targeted access to large and mid-sized companies in Italy, with a heavy focus on the financial sector and holdings like UniCredit and Intesa Sanpaolo.
Read more on EWI →
